Literature DB >> 26400219

Analytic approaches for research priority-setting: issues, challenges and the way forward.

Lazaros Andronis1.   

Abstract

In the last two decades, growing demand for studies assessing healthcare interventions, coupled with the acknowledgment that limited public funds for research ought to be allocated efficiently, has led to increasing calls for the use of analytic approaches for research prioritization. Two main approaches have been proposed - 'value of information' and 'prospective payback of research' - but neither of them is used formally in the prioritization process. This article discusses possible barriers to the formal adoption and use of analytic approaches. These include uncertainties around the appropriateness of using results of analytic approaches for priority-setting, questions around the validity of the results and challenges in introducing and using analytical methods as part of the prioritization process. It is argued that most of these challenges can be overcome and ways of doing so are discussed. The author's view on the direction and pace of future developments is provided, followed by recommendations for further research.

Entities:  

Keywords:  decision-making; prospective payback of research; research funding; research prioritization; value of information

Mesh:

Year:  2015        PMID: 26400219     DOI: 10.1586/14737167.2015.1087317

Source DB:  PubMed          Journal:  Expert Rev Pharmacoecon Outcomes Res        ISSN: 1473-7167            Impact factor:   2.217


  2 in total

1.  Cost-Effectiveness of Treatments for the Management of Bone Metastases: A Systematic Literature Review.

Authors:  Lazaros Andronis; Ilias Goranitis; Sue Bayliss; Rui Duarte
Journal:  Pharmacoeconomics       Date:  2018-03       Impact factor: 4.981

2.  Directing research funds to the right research projects: a review of criteria used by research organisations in Australia in prioritising health research projects for funding.

Authors:  Haitham W Tuffaha; Najwan El Saifi; Suzanne K Chambers; Paul A Scuffham
Journal:  BMJ Open       Date:  2018-12-22       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.